semaglutide weight stall The GLP-1 Plateau: What It Is and How to Get Past It Breaking a Weight-Loss Plateau with

Sharing needles or pens carries a significant risk of spreading serious diseases

Lipodystrophy, the formation of permanent lumps or pits in the fat layer, is the long-term consequence of poor site rotation

Dosage and administration of semaglutide are important considerations

In clinical trials of semaglutide 2.4 mg for weight management (STEP 1), approximately 44% of participants experienced nausea, compared to about 16% in placebo groups

Preventing Common Injection-Site Complications Lipohypertrophy, characterized by thickened or lumpy tissue at injection sites, develops when the same area receives repeated injections over weeks or months

Significant results typically develop within 23 months